With Hemophilia A Therapy Approval, FDA Paves the Way for Further Gene Therapy Treatments
The FDA’s recent approval of Roctavian marks the first approved gene therapy for adults with severe hemophilia A.
The FDA’s recent approval of Roctavian marks the first approved gene therapy for adults with severe hemophilia A.
This year’s National Association of Specialty Pharmacy conference takes place Sept. 18-21, 2023, at the Gaylord Texan Resort and Convention Center in Grapevine, Texas. The NASP conference will focus on providing information and insight into the CORE aspects of clinical pharmacy: Clinical, Operational, Regulatory and Experience. With over 40 education sessions, six workshops, and several
National Association of Specialty Pharmacy 2023: NASP Conference Preview Read More »
Identifying the right key stakeholders early and including them in the planning offers a greater chance for pharma product launch success.
For a Successful Pharma Product Launch, Get the Right Key Stakeholders Read More »
Patient-reported outcomes (PROs) are a valuable source of information. To unlock the data’s insights, manage it effectively.
Intermediaries in the distribution chain, pharmacy benefit managers (PBMs) play a key role in connecting patients to rare disease treatments.
Pharmacy Benefit Managers (PBMs): Key Players in Connecting Patients to Treatment Read More »
U.S. personal medical debt tops $140 billion, which has led to a prescription fill rates drop and has worsened patient outcomes.
As Patient Debt Rises, Prescription Fill Rates Drop Read More »
We connect the dots between time to paid fill and paid fill rate. The longer the time, the less prescriptions are filled.
Connecting the Dots Between Time to Paid Fill and Paid Fill Rate Read More »
Why do some patients never fill their prescriptions? Here’s a look at the four main reasons for prescription cancellation.
Why Prescriptions for Specialty Therapies Don’t Get Filled Read More »
An Inflation Reduction Act provision intended to boost orphan drug research may have the opposite effect.
Inflation Reduction Act: New Uses for Orphan Drugs Face Challenges Read More »
Do you have the tools and processes necessary to protect patient data? Here’s what to consider.
Protecting Patient Data From Key Security Risks Read More »